Activity from announced rounds
FNZ provides an end-to-end wealth-management platform to banks, wealth managers, insurers and asset managers. Its technology connects customer and adviser experiences with investment products, account administration and operational services, enabling financial institutions to launch and run digital saving and investing propositions for end investors.
Develops AI software and autonomous systems for military and national security applications
Beeline Medicines develops clinical-stage therapies that target immune dysfunction in lupus and other autoimmune and inflammatory diseases.
Kailera Therapeutics develops oral and injectable medicines for obesity using several GLP-1-based mechanisms.
Beeline Medicines develops clinical-stage therapies that target immune dysfunction in lupus and other autoimmune and inflammatory diseases.